Intravenous immunoglobulins for rituximab-resistant mucous membrane pemphigoid

J Eur Acad Dermatol Venereol. 2018 Aug;32(8):e321-e324. doi: 10.1111/jdv.14873. Epub 2018 Mar 6.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Drug Resistance
  • Female
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use*
  • Immunologic Factors / therapeutic use*
  • Male
  • Middle Aged
  • Pemphigoid, Benign Mucous Membrane / drug therapy*
  • Rituximab / therapeutic use

Substances

  • Immunoglobulins, Intravenous
  • Immunologic Factors
  • Rituximab